162 related articles for article (PubMed ID: 19900100)
41. GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
Ahrens WA; Ridenour RV; Caron BL; Miller DV; Folpe AL
Hum Pathol; 2008 Oct; 39(10):1519-26. PubMed ID: 18620729
[TBL] [Abstract][Full Text] [Related]
42. The role of core needle biopsy in the diagnosis of suspected soft tissue tumours.
Strauss DC; Qureshi YA; Hayes AJ; Thway K; Fisher C; Thomas JM
J Surg Oncol; 2010 Oct; 102(5):523-9. PubMed ID: 20872955
[TBL] [Abstract][Full Text] [Related]
43. Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.
Wisman GB; Hollema H; Helder MN; Knol AJ; Van der Meer GT; Krans M; De Jong S; De Vries EG; Van der Zee AG
Int J Oncol; 2003 Nov; 23(5):1451-9. PubMed ID: 14532990
[TBL] [Abstract][Full Text] [Related]
44. Influence of telomerase activity on bone and soft tissue tumors.
Umehara N; Ozaki T; Sugihara S; Kunisada T; Morimoto Y; Kawai A; Nishida K; Yoshida A; Murakami T; Inoue H
J Cancer Res Clin Oncol; 2004 Jul; 130(7):411-6. PubMed ID: 15160288
[TBL] [Abstract][Full Text] [Related]
45. Expression of human telomerase reverse transcriptase in gastrointestinal stromal tumors occurs preferentially in malignant neoplasms.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2004 Oct; 35(10):1231-5. PubMed ID: 15492990
[TBL] [Abstract][Full Text] [Related]
46. Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy.
Martin JA; DeYoung BR; Gitelis S; Weydert JA; Klingelhutz AJ; Kurriger G; Buckwalter JA
Clin Orthop Relat Res; 2004 Sep; (426):117-24. PubMed ID: 15346061
[TBL] [Abstract][Full Text] [Related]
47. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
48. Role of protein phosphatase in malignant osteogenic and soft tissue tumors.
Sogawa K; Yamada T; Sugita A; Kito K; Tachibana M; Nezu K; Ueda N
Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):33-42. PubMed ID: 8865368
[TBL] [Abstract][Full Text] [Related]
49. Cell-type- and tumour-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours.
Miettinen M; Sarlomo-Rikala M; Kovatich AJ
Virchows Arch; 1998 Sep; 433(3):255-60. PubMed ID: 9769129
[TBL] [Abstract][Full Text] [Related]
50. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
[TBL] [Abstract][Full Text] [Related]
51. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.
Boltze C; Mundschenk J; Unger N; Schneider-Stock R; Peters B; Mawrin C; Hoang-Vu C; Roessner A; Lehnert H
J Clin Endocrinol Metab; 2003 Sep; 88(9):4280-6. PubMed ID: 12970299
[TBL] [Abstract][Full Text] [Related]
52. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Yano Y; Yoshida K; Osaki A; Toge T; Tahara H; Ide T; Yasui W
Anticancer Res; 2002; 22(6C):4101-7. PubMed ID: 12553039
[TBL] [Abstract][Full Text] [Related]
53. Expression of human telomerase catalytic protein in gallbladder carcinogenesis.
Luzar B; Poljak M; Cör A; Klopcic U; Ferlan-Marolt V
J Clin Pathol; 2005 Aug; 58(8):820-5. PubMed ID: 16049283
[TBL] [Abstract][Full Text] [Related]
54. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
55. [Location expression of human telomerase reverse transcriptase in lung cancer, benign lesion and normal lung tissue].
Wang X; Zhang Z; He M
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):461-4. PubMed ID: 11718034
[TBL] [Abstract][Full Text] [Related]
56. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
57. Enzyme histochemical investigations on bone and soft tissue tumours.
Bendix-Hansen K; Myhre-Jensen O
Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):73-80. PubMed ID: 3984737
[TBL] [Abstract][Full Text] [Related]
58. Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.
Günther T; Schneider-Stock R; Häckel C; Pross M; Schulz HU; Lippert H; Roessner A
Clin Cancer Res; 2000 May; 6(5):1811-8. PubMed ID: 10815902
[TBL] [Abstract][Full Text] [Related]
59. PD-1 and PD-L1 expression in bone and soft tissue sarcomas.
Torabi A; Amaya CN; Wians FH; Bryan BA
Pathology; 2017 Aug; 49(5):506-513. PubMed ID: 28688724
[TBL] [Abstract][Full Text] [Related]
60. Chondrosarcoma is not characterized by detectable telomerase activity.
Bovée JV; van Den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2001 Mar; 193(3):354-60. PubMed ID: 11241416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
